Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-20-017370
Filing Date
2020-07-13
Accepted
2020-07-13 17:10:06
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K f10k2019a2_actiniumpharma.htm 10-K/A 77687
2 CERTIFICATION f10k2019a2ex31-1_actinium.htm EX-31.1 3993
3 CERTIFICATION f10k2019a2ex31-2_actinium.htm EX-31.2 3877
  Complete submission text file 0001213900-20-017370.txt   86659
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36374 | Film No.: 201025766
SIC: 2834 Pharmaceutical Preparations